معرفی
Associate Professor Veysel Kayser is a faculty member in the School of Pharmacy at the University of Sydney. He holds a Ph.D. from the University of Leeds (UK) and conducted postdoctoral research at the Max-Planck Institute (Germany) and MIT (USA). His research focuses on vaccine and biologic development, including novel vaccine formulations, monoclonal antibodies, and nanoparticle-based therapies. He consults for governments, pharmaceutical companies, and legal firms.
Education: Ph.D., University of Leeds; Postdoctoral work at MIT and Max-Planck Institute.
Research Interests:
- Vaccine development (influenza, rabies, SARS)
- Biologics (biosimilars, antibody-drug conjugates)
- Formulation and stabilization of biotherapeutics
- Nanoparticle-based drug delivery
Key Projects:
- Antibody aggregation research
- Rapid screening methods for vaccines
- Iron-gold hybrid nanoparticles for vaccines
- Biosimilar optimization
Grants and Funding:
- Australian government and industry grants for biologics development
- Sydney Institute for Infectious Diseases seed grants
Labs/Teams: Member of the Centre for Drug Discovery Innovation.
۰مقاله منتشرشده
